Back to Search

A Phase II, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

  • Protocol Number: 202108029
  • Principal Investigator: Waqar, Saiama
  • Cancer Types: Lung

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions